Work

Nirsevimab decreased the subsequent risk of respiratory syncytial virus infection and wheezing in the 2023–2024 RSV season

Year: 2025

Type: article

Source: Pediatric Research

DOI: 10.1038/s41390-024-03782-4

Authors: Kevin Sheng-Kai Ma, Serena Y. Tsai, Chadi M. El Saleeby, Camille N. Kotton, Jonathan M. Mansbach

Institutions: University of Pennsylvania, Massachusetts General Hospital, Harvard University, Boston Children's Hospital

Language: English

Topic: Respiratory viral infections research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4406217384

FWCI: 9.837

Cites: 9

Cited by: 18

Related to: 10